Standardized eCOA questionnaire library will speed study start up: Medidata

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/TiuCheung)
(Image: Getty/TiuCheung)

Related tags Medidata Medidata rave Mapi Research Trust Epro eCOA

Medidata is building a global library of pre-configured, pre-approved eCOA questionnaires to accelerate study start-up in collaboration with Icon's Mapi Research Trust – “a win-win-win” for all involved.

As part of the collaboration, Medidata will standardize Mapi Research Trust’s (MRT) library of eCOA (clinical outcomes assessment) questionnaires in the Medidata Rave eCOA.

The non-profit arm of Mapi Group, acquired by Icon in 2017​, MRT provides patient-reported outcomes (PRO) data and has assembled a library of more than 470 eCOA forms and 7,000 translations representing 190 instrument developers.

“The ePRO industry is large,” ​said Anthony Costello, vice president of Mobile Health at Medidata, “There are thousands of ePRO components on clinical trials every year all around the world and it’s been a challenge for a long time to get these studies up and running quickly,because most of the technology providers are custom-building forms over and over on each study andredoing translations for those forms.”

To address this challenge, Medidata has over the last year aspired to collate a ‘true global library,’ building these forms once and translating them into as many languages as possible, Costello told us. Author agreements also will be pre-approved so that sponsors don’t have to seek approval for each individual study.

“On the sponsor side, the pharma companies want to see faster study starts,”​ said Costello. “Having this library in place allows them to grab prebuilt, pre-translated forms out of the library instead of having to wait for someone to build it.”

The value of MRT joining this effort is that the company is responsible for hundreds of different forms and interacts with thousands – representing authors as a sort of ‘clearing house,’ he explained.

“For [MRT], they get Medidata platform technology that’s capable of housing a library like this in ways that most of our competitors just are not capable of doing,”​ added Costello.

While MRT is the largest provider involved in the project, Medidata is working with other authors and instrument owners who have agreed to help build the global library.

Katrin Conway, managing director of Mapi Research Trust, said in a statement that the library aims to cut timelines by as much as 50-60%

“[Sponsors] get the speed, the authors get the consistency, and Medidata hosts the library,”​ said Costello, calling the project “a win-win-win for all the different groups that work together on these kinds of trials.”

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

Related suppliers

Follow us

Products

View more

Webinars